INVO Fertility, Inc. filed a Form 8-K on November 4, 2026, disclosing that a 1-for-4 reverse stock split of its common stock became effective at 12:01 a.m. Eastern Time on October 30, 2026.

Key Highlights

  • Split ratio: Every 4 shares of issued and outstanding common stock were automatically reclassified and combined into one share, with no change in par value per share of $0.0001.
  • Authorized shares reduced: A proportionate adjustment reduced authorized common stock to 62,500,000 shares.
  • Trading date: Common stock began trading on a split-adjusted basis when Nasdaq opened on October 30, 2026.
  • New CUSIP number: The security has been assigned CUSIP number 44984F872, while continuing to trade under the symbol "IVF" on The Nasdaq Capital Market.
  • Fractional shares: No fractional shares were issued; stockholders holding shares directly had their holdings rounded up to the next whole share, while street-name holders received a cash payment administered by their broker or nominee.
  • Related adjustments: Proportionate adjustments were made to per share exercise prices and share counts for all outstanding stock options, warrants, and equity incentive compensation plan reserves.

INVO Fertility's Reverse Stock Split: Details and Mechanics

According to the filing, INVO Fertility, Inc. (NASDAQ:IVF) filed a Certificate of Change with the Secretary of State of Nevada, effective October 30, 2026, to implement the 1-for-4 reverse stock split. The company disclosed that the split became effective at 12:01 a.m. Eastern Time on that date and that shares began trading on a split-adjusted basis when The Nasdaq Stock Market opened the same morning.

The filing states that the reverse stock split did not alter the par value of the common stock, which remains $0.0001 per share. The company's authorized share count was reduced proportionately, resulting in 62,500,000 authorized shares of common stock. The filing also notes that proportionate adjustments were applied to the per share exercise price and the number of shares issuable under all outstanding stock options and warrants, as well as shares reserved under the company's equity incentive compensation plans.

Regarding fractional shares, the filing specifies that no fractional shares were issued in connection with the reverse stock split. Stockholders who would have been entitled to fractional shares had their holdings rounded up to the next whole share. Those holding shares in street name through a broker or nominee who would have otherwise received a fractional share instead received a cash payment, the amount of which was determined and administered by the applicable broker or nominee in accordance with their standard procedures. The company disclosed that a press release announcing the reverse stock split was issued on October 27, 2026, and is attached as Exhibit 99.1 to the filing.

What Was Disclosed

INVO Fertility, Inc. reported a 1-for-4 reverse stock split effective October 30, 2026, reducing authorized shares to 62,500,000, assigning a new CUSIP number (44984F872), and triggering proportionate adjustments to stock options, warrants, and equity plan reserves.